Information and Updates

Coronary Artery Disease Market Size

• The global coronary artery disease market was valued at USD 24.97 million in 2024 and is expected to reach USD 49.25 billion by 2032

• During the forecast period of 2025 to 2032 the market is likely to grow at a CAGR of 8.86% primarily driven by the increasing prevalence of coronary artery disease (CAD), rising aging population, advancements in medical technology, and growing awareness about heart health

𝐕𝐢𝐬𝐢𝐭 𝐮𝐬 𝐧𝐨𝐰 -

The Connected Care Market was valued at USD 145.38 billion in 2025 and is projected to reach USD 1485.30 billion by 2033, growing at a CAGR of 33.71% from 2026 to 2033. The Connected Care Market is experiencing strong growth driven by the increasing adoption of digital health technologies, rising prevalence of chronic diseases, expanding use of remote patient monitoring solutions, and growing demand for integrated healthcare delivery systems. Advancements in cloud computing, Internet of Things (IoT)-enabled medical devices, artificial intelligence, and telehealth platforms are enabling healthcare providers to deliver more efficient, patient-centered, and data-driven care across diverse healthcare settings.

𝐕𝐢𝐬𝐢𝐭 𝐮𝐬 𝐧𝐨𝐰 -

Liquid Biopsy: A Simple, Clear Guide to How It Works, What It Detects, and Why It’s Transforming Early Diagnosis

A liquid biopsy is a modern, minimally invasive test that detects cancer-related biomarkers from a sample of blood — instead of taking tissue from a tumor. It helps clinicians understand what’s happening inside the body at the molecular level without surgery.

Because it can identify cancer early, track tumor changes in real time, and guide personalized treatment, liquid biopsy is becoming one of the most important innovations in precision healthcare.

What Is a Liquid Biopsy?

A liquid biopsy analyzes tiny traces of tumor-derived material circulating in blood or other body fluids. These include:

ctDNA (circulating tumor DNA)